These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 38128937)
21. Better use of inhaled medication in asthma and COPD through training, preparation and counselling: the On TRACk study protocol for a cluster randomised controlled trial. Paske RT; van Dijk L; Linn AJ; van Boven JFM; Koster ES; Vervloet M BMJ Open; 2022 Sep; 12(9):e061266. PubMed ID: 36691116 [TBL] [Abstract][Full Text] [Related]
22. Improving rural and regional access to long-acting reversible contraception and medical abortion through nurse-led models of care, task-sharing and telehealth (ORIENT): a protocol for a stepped-wedge pragmatic cluster-randomised controlled trial in Australian general practice. Mazza D; Shankar M; Botfield JR; Moulton JE; Chakraborty SP; Black K; Tomnay J; Bateson D; Church J; Laba TL; Kasza J; Norman WV BMJ Open; 2023 Mar; 13(3):e065137. PubMed ID: 36948556 [TBL] [Abstract][Full Text] [Related]
23. Study protocol: long-term effect of the New Nordic Renal Diet on phosphorus and lipid homeostasis in patients with chronic kidney disease, stages 3 and 4: a randomised controlled trial. Hansen NM; Rix M; Kamper AL; Feldt-Rasmussen B; Christoffersen C; Astrup A; Salomo L BMJ Open; 2021 Aug; 11(8):e045754. PubMed ID: 34462278 [TBL] [Abstract][Full Text] [Related]
24. Preparing for responsive management versus preparing for renal dialysis in multimorbid older people with advanced chronic kidney disease (Prepare for Kidney Care): Study protocol for a randomised controlled trial. Worthington J; Soundy A; Frost J; Rooshenas L; MacNeill SJ; Realpe Rojas A; Garfield K; Liu Y; Alloway K; Ben-Shlomo Y; Burns A; Chilcot J; Darling J; Davies S; Farrington K; Gibson A; Husbands S; Huxtable R; McNally H; Murphy E; Murtagh FEM; Rayner H; Rice CT; Roderick P; Salisbury C; Taylor J; Winton H; Donovan J; Coast J; Lane JA; Caskey FJ Trials; 2024 Oct; 25(1):688. PubMed ID: 39420412 [TBL] [Abstract][Full Text] [Related]
25. Deprescribing to reduce polypharmacy: study protocol for a randomised controlled trial assessing deprescribing of anticholinergic and sedative drugs in a cohort of frail older people living in the community. Bergler U; Ailabouni NJ; Pickering JW; Hilmer SN; Mangin D; Nishtala PS; Jamieson H; Trials; 2021 Nov; 22(1):766. PubMed ID: 34732234 [TBL] [Abstract][Full Text] [Related]
26. Evaluation of a community pharmacy-based intervention for improving patient adherence to antihypertensives: a randomised controlled trial. Lau R; Stewart K; McNamara KP; Jackson SL; Hughes JD; Peterson GM; Bortoletto DA; McDowell J; Bailey MJ; Hsueh A; George J BMC Health Serv Res; 2010 Feb; 10():34. PubMed ID: 20137091 [TBL] [Abstract][Full Text] [Related]
27. Integrated model of secondary fracture prevention in primary care (INTERCEPT): protocol for a cluster randomised controlled multicentre trial. Wang M; Knight A; Demeshko A; Girgis CM; Bolton P; Das A; Auwyang A; Williams B; Moses D; D'Este C; Seibel MJ BMC Prim Care; 2024 Sep; 25(1):349. PubMed ID: 39342106 [TBL] [Abstract][Full Text] [Related]
28. Effectiveness of Pharmacist Interventions on Cardiovascular Risk in Patients With CKD: A Subgroup Analysis of the Randomized Controlled R Al Hamarneh YN; Tsuyuki RT; Jones CA; Manns B; Tonelli M; Scott-Douglass N; Jindal K; Tink W; Hemmelgarn BR Am J Kidney Dis; 2018 Jan; 71(1):42-51. PubMed ID: 28912054 [TBL] [Abstract][Full Text] [Related]
29. Electronic Health Record Population Health Management for Chronic Kidney Disease Care: A Cluster Randomized Clinical Trial. Jhamb M; Weltman MR; Devaraj SM; Lavenburg LU; Han Z; Alghwiri AA; Fischer GS; Rollman BL; Nolin TD; Yabes JG JAMA Intern Med; 2024 Jul; 184(7):737-747. PubMed ID: 38619824 [TBL] [Abstract][Full Text] [Related]
30. Reducing the burden of knee osteoarthritis through community pharmacy: Protocol for a randomised controlled trial of the Knee Care for Arthritis through Pharmacy Service. Darlow B; Brown M; Stanley J; Abbott JH; Briggs AM; Clark J; Frew G; Grainger R; Hood F; Hudson B; Keenan R; Marra C; McKinlay E; Pask A; Pierobon A; Simmonds S; Vincent L; Wilson R; Dean S Musculoskeletal Care; 2023 Dec; 21(4):1053-1067. PubMed ID: 37212721 [TBL] [Abstract][Full Text] [Related]
31. Effect of 2 Clinical Decision Support Strategies on Chronic Kidney Disease Outcomes in Primary Care: A Cluster Randomized Trial. Carroll JK; Pulver G; Dickinson LM; Pace WD; Vassalotti JA; Kimminau KS; Manning BK; Staton EW; Fox CH JAMA Netw Open; 2018 Oct; 1(6):e183377. PubMed ID: 30646261 [TBL] [Abstract][Full Text] [Related]
32. Integrating Risk-Based Care for Patients With Chronic Kidney Disease in the Community: Study Protocol for a Cluster Randomized Trial. Harasemiw O; Drummond N; Singer A; Bello A; Komenda P; Rigatto C; Lerner J; Sparkes D; Ferguson TW; Tangri N Can J Kidney Health Dis; 2019; 6():2054358119841611. PubMed ID: 31191908 [TBL] [Abstract][Full Text] [Related]
33. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study. Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796 [TBL] [Abstract][Full Text] [Related]
34. Family conferences and shared prioritisation to improve patient safety in the frail elderly (COFRAIL): study protocol of a cluster randomised intervention trial in primary care. Mortsiefer A; Wilm S; Santos S; Löscher S; Wollny A; Drewelow E; Ritzke M; Thürmann P; Mann NK; Meyer G; Abraham J; Icks A; Montalbo J; Wiese B; Altiner A; Trials; 2020 Mar; 21(1):285. PubMed ID: 32197631 [TBL] [Abstract][Full Text] [Related]
35. A pharmacist based intervention to improve the care of patients with CKD: a pragmatic, randomized, controlled trial. Cooney D; Moon H; Liu Y; Miller RT; Perzynski A; Watts B; Drawz PE BMC Nephrol; 2015 Apr; 16():56. PubMed ID: 25881226 [TBL] [Abstract][Full Text] [Related]
36. Community Pharmacy-Based eGFR Screening for Early Detection of CKD in High Risk Patients. Papastergiou J; Donnelly M; Li W; Sindelar RD; van den Bemt B Can J Kidney Health Dis; 2020; 7():2054358120922617. PubMed ID: 32523707 [TBL] [Abstract][Full Text] [Related]
37. Cross-sectional observation study to investigate the impact of risk-based stratification on care pathways for patients with chronic kidney disease: protocol paper. Bhachu HK; Cockwell P; Subramanian A; Nirantharakumar K; Kyte D; Calvert M BMJ Open; 2019 Jun; 9(6):e027315. PubMed ID: 31182446 [TBL] [Abstract][Full Text] [Related]
38. NAV-KIDS van Zwieten A; Caldwell P; Howard K; Tong A; Craig JC; Alexander S; Howell M; Armando TP; Hawley C; Jesudason S; Walker A; Mackie F; Kennedy S; McTaggart S; McCarthy H; Carter S; Kim S; Crafter S; Woodleigh R; Guha C; Wong G BMC Nephrol; 2019 Apr; 20(1):134. PubMed ID: 30999884 [TBL] [Abstract][Full Text] [Related]
39. Reducing medicine-induced deterioration and adverse reactions (ReMInDAR) trial: study protocol for a randomised controlled trial in residential aged-care facilities assessing frailty as the primary outcome. Lim R; Bereznicki L; Corlis M; Kalisch Ellett LM; Kang AC; Merlin T; Parfitt G; Pratt NL; Rowett D; Torode S; Whitehouse J; Andrade AQ; Bilton R; Cousins J; Kelly L; Schubert C; Williams M; Roughead EE BMJ Open; 2020 Apr; 10(4):e032851. PubMed ID: 32327474 [TBL] [Abstract][Full Text] [Related]